Welcome to our dedicated page for JANUS LIVING SEC filings (Ticker: JAN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for JanOne Inc. under the historical ticker JAN provides access to regulatory documents that trace the company’s corporate evolution into ALT5 Sigma Corporation and its development as a fintech and healthcare-focused issuer. These filings, which include Forms 8-K and other reports, document material events such as acquisitions, capital raises, governance changes, and the formal confirmation of the corporate name and ticker symbol change from JanOne Inc. (JAN) to ALT5 Sigma Corporation (ALTS).
Investors can review filings that describe the acquisition of blockchain financial technology provider ALT5 Sigma Inc. and its subsidiaries, the company’s inclusion in the Russell Microcap Index, and subsequent transactions involving registered direct offerings, private placements, and the establishment of a cryptocurrency treasury strategy involving WLFI tokens. Other filings outline the purchase of the Mswipe business, which offers multi-currency, fiat- and crypto-enabled payment card services, and detail the related consideration, warrants, and promissory notes.
These documents also provide insight into the company’s governance and oversight, including board and committee changes, compensation arrangements for executives, and the formation of special committees to review specific matters. For those studying the company’s biotech activities, periodic reports and current reports can be used to follow disclosures about its efforts to develop non-addicting pain treatments and address the opioid crisis.
On Stock Titan, SEC filings for JAN serve primarily as a historical record, since the company has adopted the name ALT5 Sigma Corporation and trades under the ticker ALTS. Users can use this page to locate past 8-Ks and related filings associated with the JAN symbol, then follow the sequence of disclosures into the ALT5 Sigma era. AI-powered tools on the platform can help summarize lengthy filings, highlight key terms of transactions, and make complex capital structure and governance information easier to interpret.
On August 11, 2025, ALT5 Sigma Corporation announced concurrent capital transactions that are expected to materially change its balance sheet and governance. The Company agreed to a registered direct offering to issue 100,000,000 shares at $7.50 per share (expected gross proceeds $750 million) and a concurrent private placement in which it received $750 million of $WLFI tokens from the Lead Investor in exchange for 1,000,000 shares at $7.50 and pre-funded warrants to purchase up to 99,000,000 additional shares.
The Company said it will use up to $10.0 million of net proceeds to settle litigation, pay debt and fund operations, with the remainder to purchase WLFI tokens and establish a cryptocurrency treasury. ALT5 also entered an ATM sales agreement to sell up to $1.0 billion of Common Stock, disclosed preliminary Q2 estimates (13-week revenue $6.0–6.5M; 26-week revenue $11.5–12.5M; cash ~ $9.5M; total assets ~$94–95M; current liabilities $58–59M) and announced board and management appointments, including Zachary Witkoff and Eric Trump.